Literature DB >> 9066621

Timing of surgery related to menstrual cycle and prognosis of premenopausal women with breast cancer.

G Mondini1, F Decian, G Sorice, D Friedman, C Spirito, M Costantini, M P Sormani, D Civalleri.   

Abstract

The influence of the timing of surgery in relation to the menstrual cycle on the survival of breast cancer patients has been both advocated and disputed. The records of 165 premenopausal M- breast cancer women consecutively operated from 1977 to 1991 were reviewed. All patients underwent modified radical mastectomies or quadrantectomies plus postoperative radiotherapy. Node-positive patients received adjuvant chemotherapy. Cox regression analysis was used to estimate the relative risk (RR) of death in three models including timing of surgery, age, histology, pT and pN. In each model, patients were divided into two groups according to the criteria proposed by Badwe, Hrushesky, and Senie. Multivariate analysis showed a significant association between pT and pN and survival, whereas no association with survival was observed for the timing of surgery according to either Badwe or Hrushesky or Senie (RR = 1.26, RR = 0.91 and RR = 0.88 respectively). Consensus on the menstrual phase related to the expected best prognosis is still required.

Entities:  

Mesh:

Year:  1997        PMID: 9066621

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

Review 2.  Timing of breast surgery in premenopausal breast cancer patients.

Authors:  Miny Samuel; Khin Lay Wai; Victoria K Brennan; Wei Sean Yong
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

3.  Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update.

Authors:  Anushka Chaudhry; Michael L Puntis; Panos Gikas; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2006-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.